Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab, Cisplatin, and IMRT for Recurrent Head and Neck Cancer
NCT00833261Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2008
- Primary completion
- Sep 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by UT Southwestern Medical Center. Started Dec 2008; status: completed.
02
Drugs
cetuximab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00833261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833261.